Literature DB >> 2049575

Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome.

B P Wordsworth1, D J Ogilvie, B C Sykes.   

Abstract

Type II Ehlers-Danlos syndrome (EDS) is one of a group of disorders characterized by striking abnormalities of the soft connective tissues. The major fibrillar collagens (types I and III) found in these tissues have important stress-bearing functions and abnormal collagen could therefore account for the clinical features of this condition. We have used a number of restriction site dimorphisms, tightly linked to the structural genes of type I collagen (COL1A1 COL1A2) and type III collagen (COL3A1), to investigate the segregation of corresponding alleles in three pedigrees in which type II EDS was clearly inherited as a dominant trait. Discordant segregation of all three collagen genes was seen in a large pedigree that included 17 affected individuals with the typical phenotype of type II EDS. Thus mutations in neither type I nor type III collagen genes were responsible for the disease in this family. In a second small pedigree discordant segregation of the disease with both type I collagen loci was observed while the concordant segregation seen at COL3A1 could easily have arisen by chance (P = 0.5). The third pedigree was uninformative at all three collagen loci because of inability to discriminate between the parental alleles. These results suggest that there may be molecular heterogeneity of type II EDS since abnormalities of type I collagen have been described in other individuals phenotypically similar to those in our study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049575     DOI: 10.1093/rheumatology/30.3.173

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

1.  Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).

Authors:  U Schwarze; M Atkinson; G G Hoffman; D S Greenspan; P H Byers
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

2.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon.

Authors:  Richard J Wenstrup; Simone M Smith; Jane B Florer; Guiyun Zhang; David P Beason; Robert E Seegmiller; Louis J Soslowsky; David E Birk
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

4.  COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.

Authors:  R J Wenstrup; J B Florer; M C Willing; C Giunta; B Steinmann; F Young; M Susic; W G Cole
Journal:  Am J Hum Genet       Date:  2000-04-24       Impact factor: 11.025

5.  Identification of a de novo case of COL5A1-related Ehlers-Danlos syndrome in an infant in the West Indies leading to improved targeted clinical care.

Authors:  Amr Wardeh; Tyson Jackson; Beverly Nelson; Carl Ernst; Jean-François Théroux; Walla Al-Hertani; Andrew K Sobering; Mary C Maj
Journal:  Clin Case Rep       Date:  2018-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.